Ewa B. Hoffmann
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
-
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Rachel Fynvola Tyndale (20 shared papers)Edward M. Sellers (5 shared papers)Sharon L. Miksys (5 shared papers)Deborah C. Mash (2 shared papers)Kerri A. Schoedel (1 shared paper)Laurent Bodin (2 shared papers)Mohammad I. Zia (2 shared papers)Marilyn Zeman (2 shared papers)
- Journals
- Molecular Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)British Journal of Pharmacology (2 papers)Biological Psychiatry (2 papers)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- CanadaUnited StatesSweden
In The Last Decade
Ewa B. Hoffmann
20 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 619
- Biochemistry 135
- Physiology 415
- Biological Psychiatry 33
- Hepatology 80
Countries citing papers authored by Ewa B. Hoffmann
This map shows the geographic impact of Ewa B. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa B. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa B. Hoffmann more than expected).
Fields of papers citing papers by Ewa B. Hoffmann
This network shows the impact of papers produced by Ewa B. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa B. Hoffmann. The network helps show where Ewa B. Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ewa B. Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 250 | |
| 2 | 2000 | 204 | |
| 3 | 2013 | 135 | |
| 4 | 2002 | 134 | |
| 5 | 2003 | 122 | |
| 6 | 2002 | 118 | |
| 7 | 2007 | 112 | |
| 8 | 2000 | 106 | |
| 9 | 2011 | 85 | |
| 10 | 2007 | 77 | |
| 11 | 2008 | 74 | |
| 12 | 2008 | 61 | |
| 13 | 2009 | 59 | |
| 14 | 2016 | 35 | |
| 15 | 2013 | 33 | |
| 16 | 2014 | 28 | |
| 17 | 2000 | 23 | |
| 18 | 2000 | 15 | |
| 19 | Pentobarbital decreases the gamma-aminobutyric acidA receptor subunit gamma-2 long/short mRNA ratio by a mechanism distinct from receptor occupation. | 1997 | 9 |
| 20 | 1997 | 4 |
About Ewa B. Hoffmann
Ewa B. Hoffmann is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Biochemistry, Organic Chemistry and Molecular Biology, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Neuroscience and Neuropharmacology Research (4 papers), Synthesis and Biological Evaluation (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Receptor Mechanisms and Signaling (3 papers), Smoking Behavior and Cessation (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Behavioral Health and Interventions (1 paper). The work is most often cited by research in Pharmacology (619 citations), Biochemistry (135 citations), Physiology (415 citations), Biological Psychiatry (33 citations) and Hepatology (80 citations). Ewa B. Hoffmann has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include Rachel Fynvola Tyndale, Edward M. Sellers, Sharon L. Miksys, Deborah C. Mash, Kerri A. Schoedel, Laurent Bodin, Mohammad I. Zia, Marilyn Zeman, Caryn E. Lerman and Nael Al Koudsi. Their work appears in journals such as Molecular Pharmacology, Clinical Pharmacology & Therapeutics, British Journal of Pharmacology, Biological Psychiatry and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.